Literature DB >> 14563561

Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPase(old-35), a Type I interferon inducible early response gene.

Magdalena Leszczyniecka1, Zao-zhong Su, Dong-chul Kang, Devanand Sarkar, Paul B Fisher.   

Abstract

An overlapping pathway screening (OPS) approach designed to identify and clone genes displaying parallel expression profiles as a function of induction of terminal differentiation and cellular senescence in human cells identified a novel gene old-35. Sequence and functional analysis indicates that old-35 encodes human polynucleotide phosphorylase, hPNPase(old-35). Polynucleotide phosphorylases comprise a family of phosphate dependent 3'-5' RNA exonucleases implicated in RNA regulation. Treatment of HO-1 human melanoma and additional diverse normal and tumor-derived human cell types with Type I interferon (IFN), IFN-beta or IFN-alpha, induces hPNPase(old-35) expression. To provide insights into the regulation of hPNPase(old-35), we cloned and analyzed the promoter region of this gene. These studies demonstrate that IFN-beta controls hPNPase(old-35) expression by transcriptional modulation rather than by altering mRNA stability. Transcriptional activation of hPNPase(old-35) by IFN-beta is primarily mediated by the interferon stimulatory response element (ISRE) present in its promoter. Analysis of hPNPase(old-35) expression in cell lines defective in various IFN signaling molecules confirms that hPNPase(old-35) expression is dependent upon the Janus activated kinase (JAK)/signal transducers and activators of transcription (STAT) pathway. Furthermore, gel shift analyses document that hPNPase(old-35) is a direct target of the interferon stimulated gene factor 3 (ISGF3) complex. The hPNPase(old-35) gene spans approximately 54 kb of genomic DNA and is distributed on 28 exons and 27 introns. hPNPase(old-35) maps to 2p15-2p16.1, a region implicated in hereditary nonpolyposis colorectal cancer, Carney complex, Doyne's honeycomb retinal dystrophy and several other diseases. To provide insights into PNPase function in vivo, we have also cloned the mouse PNPase(old-35) cDNA, mPNPase(old-35). Induction of hPNPase(old-35) by IFN treatment as well as during differentiation and senescence suggest that this gene may play a significant role in regulating cellular growth and that overlapping gene expression changes, also induced by IFN, may contribute to these important physiological processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563561     DOI: 10.1016/s0378-1119(03)00752-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  17 in total

1.  A new function in translocation for the mitochondrial i-AAA protease Yme1: import of polynucleotide phosphorylase into the intermembrane space.

Authors:  Robert N Rainey; Jenny D Glavin; Hsiao-Wen Chen; Samuel W French; Michael A Teitell; Carla M Koehler
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

2.  Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776.

Authors:  Yung-Luen Yu; Ruey-Hwang Chou; Chia-Han Wu; Ying-Nai Wang; Wei-Jung Chang; Yen-Ju Tseng; Wei-Chao Chang; Chien-Chen Lai; Hong-Jen Lee; Longfei Huo; Chung-Hsuan Chen; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

3.  Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells.

Authors:  Swadesh K Das; Upneet K Sokhi; Sujit K Bhutia; Belal Azab; Zhao-Zhong Su; Devanand Sarkar; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

4.  Mammalian polynucleotide phosphorylase is an intermembrane space RNase that maintains mitochondrial homeostasis.

Authors:  Hsiao-Wen Chen; Robert N Rainey; Cynthia E Balatoni; David W Dawson; Joshua J Troke; Sylwia Wasiak; Jason S Hong; Heidi M McBride; Carla M Koehler; Michael A Teitell; Samuel W French
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

5.  Defining the domains of human polynucleotide phosphorylase (hPNPaseOLD-35) mediating cellular senescence.

Authors:  Devanand Sarkar; Eun Sook Park; Luni Emdad; Aaron Randolph; Kristoffer Valerie; Paul B Fisher
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 6.  PNPASE and RNA trafficking into mitochondria.

Authors:  Geng Wang; Eriko Shimada; Carla M Koehler; Michael A Teitell
Journal:  Biochim Biophys Acta       Date:  2011-10-13

7.  Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.

Authors:  Mihaela Stefan-Lifshitz; Esra Karakose; Lingguang Cui; Abora Ettela; Zhengzi Yi; Weijia Zhang; Yaron Tomer
Journal:  JCI Insight       Date:  2019-03-07

8.  Crystal structure of Escherichia coli PNPase: central channel residues are involved in processive RNA degradation.

Authors:  Zhonghao Shi; Wei-Zen Yang; Sue Lin-Chao; Kin-Fu Chak; Hanna S Yuan
Journal:  RNA       Date:  2008-09-23       Impact factor: 4.942

9.  Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.

Authors:  Catherine O'Doherty; Alexander Favorov; Shirley Heggarty; Colin Graham; Olga Favorova; Michael Ochs; Stanley Hawkins; Michael Hutchinson; Killian O'Rourke; Koen Vandenbroeck
Journal:  Pharmacogenomics       Date:  2009-07       Impact factor: 2.533

10.  Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastoma.

Authors:  Tom Van Maerken; Devanand Sarkar; Frank Speleman; Paul Dent; William A Weiss; Paul B Fisher
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.